COLUMN

• Mission Impossible: Finding the Right Leader to Launch a Disruptive Medical Technology into Japan
  August 10, 2023

• How Healthcare Companies Should Hire in the Post-COVID Work Environment
  July 19, 2023

• The Impact of a Shrinking Labor Market on the Healthcare Industry
  June 23, 2023

• Seven Recruitment Trends in 2023
  May 31, 2023

• The Inflation Reduction Act - Implications for Japanese Pharmaceutical Manufacturers
  May 19, 2023

• How to Serve and Get Ahead
  April 21, 2023

• The Increasing Impact of Real-World Evidence
  March 31, 2023

• Rewarding Value and Innovation and Ensuring Financial Viability of the Biopharmaceutical Supply Chain in Japan
  March 16, 2023

• Why Market Mapping Is Critical to Your Organization
  February 24, 2023

• When It Comes to Recruitment, Time Is Money. Have a Plan!
  January 31, 2023

• Cell Therapy in Japan: A Potentially Attractive Market at a Turning Point Facing Challenges
  December 16, 2022

• How to Succeed in Bad Times and Good
  December 9, 2022

• The Pros and Cons of Working from Home in 2022
  November 25, 2022

• Rare Diseases in Japan: Moving from Treatment to Integrated Care
  October 27, 2022

• The Evolving US Managed Care Environment and Implications of US Market Attractiveness for Japanese Manufacturers
  September 5, 2022

• Fairness, Not Diversity
  August 26, 2022

• Healthcare Collaboration between Governments and Biopharma: Key Success Factors for Life Science Manufacturers and Future Implications
  August 5, 2022

• The Winning Combination: Drive, Passion, and Commitment
  July 22, 2022

• Please Come Back to the Office!
  June 24, 2022

• Customer Engagement in the COVID-Endemic New Normal
  June 17, 2022

ページ